VorAsidenib With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations
Clinical trial NCT07629089 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07629089
- Sponsor
- Megan Mantica
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-30
- Primary completion
- 2030-06-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.